Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-Care.
Haymond A, Mueller C, Steinberg H, Hodge KA, Lehman CW, Lin SC, Collini L, Branscome H, Nguyen TV, Rucker S, Panny L, Flor R, Guirguis R, Hoefer R, Lorenzin G, Petricoin E, Kashanchi F, Kehn-Hall K, Lanzafame P, Liotta L, Luchini A.
Haymond A, et al. Among authors: flor r.
medRxiv [Preprint]. 2020 Aug 2:2020.07.30.20163824. doi: 10.1101/2020.07.30.20163824.
medRxiv. 2020.
PMID: 32766594
Free PMC article.
Preprint.